CRH plc delivered a strong second quarter of 2026. The result reflects pricing discipline, an active acquisition cadence, and a deliberate portfolio rebalancing toward higher‑growth infrastructure end‑markets. Revenue advanced 6% to $10.8B. Net income reached $1.5B. The quarter also marked the announcement of an all‑cash agreement to take the U.S. peer Arcosa private at approximately $8.5B of enterprise value. The deal is the largest in CRH's recent deal cadence and the most consequential rebalancing of the U.S. portfolio since the Eco Material Technologies transaction. The transaction reframes the long‑term growth trajectory and tests the operating system against an unfamiliar regulatory environment.
For the six months ended mid‑year, total revenue reached $18.1B. That figure is up 7% versus the comparable prior‑year stretch. Diluted earnings per share of $1.93 marked an 8% advance. The pre‑impairment diluted EPS figure of $2.01 captures underlying earnings power more clearly than the headline number. The setup heading into the second half diverges from the typical heavy‑side materials profile. Order books are extending. Divestiture proceeds have rebuilt the cash position. A freshly arranged term loan plus a reduced bridge facility underpin the Arcosa funding plan.
The market reaction to that combination has been measured. The shares trade at a forward earnings multiple near 14x against an enterprise value of $79.5B on equity of $92/share. The capital allocation pivot toward de‑levering while preserving the dividend cadence creates a measured posture for the next several quarters as integration planning advances. The dividend yield of approximately 1.7% provides defensive income through the integration window. Net debt of $15.4B sits at the wider end of the historical range and frames the credit story heading into the closing window. The combination of the buyback pause and the dividend step‑up signals deliberate prioritization of capital toward de‑levering. The base case rewards patience with modest re‑rating potential as regulatory milestones clear and the deleveraging glide path materializes into measurable credit metric progress through the next several reporting periods. The integration window is also when the market typically begins to incorporate the post‑deal earnings power into the equity multiple, and the absence of that step‑up today explains a portion of the share price discount relative to where the trailing sum‑of‑the‑parts suggests the equity should trade in a normalized scenario. Investors who underwrite the integration execution should size the position with awareness of the layered downside scenarios that the risk section describes, and should anchor expectations to the dividend yield rather than to a near‑term re‑rating thesis. The current trading band leaves room for both re‑rating and de‑rating outcomes depending on how the regulatory clearance timeline evolves and how the deleveraging glide path materializes through the next several reporting periods.